Synthesis of Novel STING Antagonists and Their Uses in Treatment of STING Related Diseases

Stimulator of interferon genes (STING) is a transmembrane protein localized to the endoplasmic reticulum that serves as a pivotal sensor of intracellular DNA in innate immunity. Following the detection of pathogen-derived or self-derived DNA in the cytosol, STING activates signaling cascades that promote the production of type I interferons and pro-inflammatory mediators. Beyond its well-established function in host defense, STING has emerged as an important regulatory node in antitumor immune surveillance, maintenance of immune tolerance, neuroinflammatory processes, and metabolic regulation. This patent overview outlines the design, synthesis, and potential therapeutic use of newly developed compounds aimed at treating disorders associated with dysregulated STING signaling.

Authors

Institutions

Publication Details

Journal
ACS Medicinal Chemistry Letters
Published
2026-03-03
DOI
https://doi.org/10.1021/acsmedchemlett.6c00098
Primary Topic
interferon and immune responses
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Synthesis of Novel STING Antagonists and Their Uses in Treatment of STING Related Diseases

Haofeng Shi, Steven H. Liang
ACS Medicinal Chemistry Letters
interferon and immune responses
article

Synthesis of Novel STING Antagonists and Their Uses in Treatment of STING Related Diseases

Haofeng Shi, Steven H. Liang
article en

Abstract

Stimulator of interferon genes (STING) is a transmembrane protein localized to the endoplasmic reticulum that serves as a pivotal sensor of intracellular DNA in innate immunity. Following the detection of pathogen-derived or self-derived DNA in the cytosol, STING activates signaling cascades that promote the production of type I interferons and pro-inflammatory mediators. Beyond its well-established function in host defense, STING has emerged as an important regulatory node in antitumor immune surveillance, maintenance of immune tolerance, neuroinflammatory processes, and metabolic regulation. This patent overview outlines the design, synthesis, and potential therapeutic use of newly developed compounds aimed at treating disorders associated with dysregulated STING signaling.

ACS Medicinal Chemistry LettersVol. 17(3)
Georgia Institute of Technology (US), Emory University (US), The Wallace H. Coulter Department of Biomedical Engineering (US)
Openalex Percentile: Top 35%
interferon and immune responses
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Synthesis of Novel STING Antagonists and Their Uses in Treatment of STING Related Diseases — Haofeng Shi, Steven H. Liang · ACS Medicinal Chemistry Letters (2026) | TGRS Research Map | TGRS